Firefly Neuroscience (AIFF) Enterprise Value (2010 - 2026)

Firefly Neuroscience's Enterprise Value history runs 17 years deep, the most recent figure standing at -$3.1 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 67.24% year-over-year to -$3.1 million in Q1 2026; TTM through Mar 2026 was -$3.1 million, a 67.24% increase from a year earlier, with the FY2025 full-year figure at -$2.7 million, down 51.77% from the prior year.
• Enterprise Value retreated to -$3.1 million in Q1 2026 per AIFF's latest filing, from -$2.7 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$58000.0 in Q4 2022 and bottomed at -$9.5 million in Q1 2025.
• The 5-year median for Enterprise Value is -$1.6 million (2022), against an average of -$2.3 million.
• Across the five-year window, Enterprise Value surged 98.82% in 2022 and plunged 3594.83% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$58000.0 in 2022, then plunged by 3594.83% to -$2.1 million in 2023, then increased by 15.54% to -$1.8 million in 2024, then slumped by 51.77% to -$2.7 million in 2025, then slipped by 13.83% to -$3.1 million in 2026.
• Per Business Quant, the three latest AIFF Enterprise Value figures stand at -$3.1 million (Q1 2026), -$2.7 million (Q4 2025), and -$4.3 million (Q3 2025).